Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
inhibition of IL-23 signaling
|
| gptkbp:appointed_by |
subcutaneous injection
|
| gptkbp:developed_by |
gptkb:Alder_Bio_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0694
|
| gptkbp:ingredients |
C23 H28 N4 O5 S
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_for |
treatment of autoimmune diseases
|
| gptkbp:targets |
gptkb:IL-23
|
| gptkbp:type_of |
123456-78-9
|
| gptkbp:weight |
460.56 g/mol
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|